Seòmar agus comataidhean

The Scottish Government remains committed to offering Covid vaccination to everyone who is eligible. We continue to do so in line with clinical advice.

Following the JCVI’s latest advice on the vaccination of younger people we are now inviting all 16 and 17 year olds to come forward for first dose.

Sixteen or 17 years olds have been able to self-register for an appointment at: https://www.nhsinform.scot/vaccineregistration since 6 August and have been able to attend mainland drop in vaccination clinics from 10 August. They can only be able to attend clinics offering Pfizer, as this is the only vaccine currently licenced for use in the under-18 age group.

Please find the requested information set out in the following table.

The new contract will see the continued provision of online assessments for children and young people in P1, P4, P7 and S3. The Specification of Requirements published as part of the Invitation to Tender identified the areas in which continuity of provision is required (general assessment principles, presentation policy and coverage; reports coverage; training coverage; branding), and highlighted some areas around which enhancements were sought. The primary difference between the phase 1 contracts and the phase 2 contract is that rather than continuing to deliver two online systems through two separate contracts, phase two will see the establishment of a single assessment platform, which will provide access to both the Scottish National Standardised Assessments (SNSA) and their Gaelic Medium Education equivalents, the Measaidhean Coitcheann Niseanta airson Foghlam tron Ghidhlig (MCNG).

The Scottish Government is in discussion with key stakeholders involved in the provision of swimming lessons and water safety education. We recognise the importance of swimming lessons in helping to build water confidence and learning to be safe in and around water, as well as the benefits swimming provides to physical and mental health. We would encourage parents/guardians to contact their local swimming lesson provider to discuss when their children are able to attend lessons.

I refer the member to the answer to question S6W-01708 on
‎ 24 August 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

On 31 May, Zero Waste Scotland in partnership with Scottish Government and Keep Scotland Beautiful launched the second phase of the anti-littering campaign, Scotland is Stunning, which targeted families and young people enjoying the outdoors.

Zero Waste Scotland has also developed a number of behaviour change initiatives and education resources aimed at school children, including the #GetLitterLiterate campaign which aims to teach students about the harmful effects of littering and mobilise them to influence their local and online communities.

Work has begun to refresh the National Litter Strategy, which has come to the end of its five year lifespan, as a National Litter and Flytipping Strategy. This refreshed strategy will be published in early 2022. Recognising the important role of education in litter prevention, communications and behaviour change has been identified as one of the four key themes which will be the focus of this refreshed strategy.

The Joint Committee on Vaccination and Immunisation (JCVI) have recommended that, where operationally possible, those aged under 40 should receive an alternative to the Oxford/AstraZeneca vaccine.

However, everybody who has already had a first dose of the Oxford/AstraZeneca vaccine should receive a second dose of the same jab, irrespective of age, except for the very small number of people who experienced blood clots with low platelet counts from their first vaccination. There have been no confirmed cases of thromboembolic events to date in second doses.

People will not be offered options on which vaccine they will receive, unless there is a clinical reason why this would be required, such as an allergy. Any vaccine authorised for use in the UK, by the appropriate Medical authorities is safe and effective, and will have a similar effect in terms of protection.

It is also worth noting that this is the case with many other vaccines. People are not routinely offered a choice of the type of vaccines in other vaccine programmes in Scotland. The Scottish Government currently has no plans to introduce an option for receiving either COVID-19 vaccine, beyond a clinical recommendation as the benefits of the vaccine continue to outweigh the risks for the vast majority of the population.

I refer Mr Mundell to the answer to S6W-01932 on 25 August 2021.

The OECD’s Independent Review of Curriculum for Excellence (CfE) was conducted using their Implementing Policies: Supporting Change in Education Framework.

The OECD had responsibility for its programme of virtual school visits and the arrangement of focus groups, and was supported by both Scottish Government officials and the Scottish Practitioner Forum.

Details of how the OECD conducted their independent review can be accessed at Independent+Review+of+Curriculum+for+Excellence+-+Remit.pdf (www.gov.scot)

All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

We currently have no plans to revise our advice on vitamin D supplementation. We will continue to be guided by the Scientific Advisory Committee on Nutrition (SACN) and others as the evidence base on vitamin D develops. We will review our advice as necessary based on their recommendations.

Our current advice on vitamin D supplementation, which is based on recommendations by SACN, advisors to the four UK nations, is available at https://www.gov.scot/publications/vitamin-d-advice-for-all-age-groups/

In terms of supplement dosage, our advice is a supplement containing 10 micrograms of vitamin D (400 IU). This applies to adults and children over one year of age. Ten micrograms per day is the average amount needed by the majority (97.5%) of the population to maintain adequate vitamin D levels when UVB sunlight exposure is minimal to maintain bone and muscle health. Our advice is based on SACN’s 2016 report; Vitamin D and Health.

This report is available at:

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/537616/SACN_Vitamin_D_and_Health_report.pdf

In December 2020, the National Institute for Health and Care Excellence (NICE), SACN, and Public Health England published updated guidance on vitamin D in relation to COVID-19 following a rapid review of recent evidence. The guidance states that there is still currently not enough evidence to support taking vitamin D solely for the prevention or treatment of COVID-19. It reiterates that people should continue to follow current advice on vitamin D supplementation to maintain bone and muscle health.

The NICE guideline is available at https://www.nice.org.uk/guidance/NG187

SACN published an updated rapid review on Vitamin D and acute respiratory tractinfections (ARTI) in December 2020. In it, SACN recommended the reference nutrient intake for vitamin D remain unchanged, at 10 micrograms per day.

The review is available at https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/945179/SACN_December2020_VitaminD_AcuteRespiratoryTractInfections.pdf

In June 2021, SACN published a paper summarising monitoring of recent evidence on nutrition and COVID-19. It did not identify any new trials in relation to vitamin D and COVID-19 that would require the re-review of the current rapid guideline from NICE, SACN and PHE, or that would change current dietary advice.

The paper is available at:

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/992875/SACN_Process_for_monitoring_evidence_on_nutrition_and_COVID-19__June21_.pdf

SACN will continue to support NICE with their monitoring of evidence on vitamin D.

The UK COVID-19 Therapeutic Advisory Panel (UK C-TAP) continues to monitor ongoing COVID-19 related Vitamin D trials. It is responsible for reviewing and prioritising suitable compounds based on promising scientific evidence. Evidence on vitamin D and on COVID-19 is also being monitored by RAPID-C19, a multi-agency initiative aiming to get treatments for COVID-19 to NHS patients quickly and safely, as well as by the National Institute for Health Research (NIHR) Innovation Observatory (IO), a national medical horizon scanning facility at Newcastle University. SACN has agreed it will no longer monitor evidence in relation to vitamin D and COVID-19/ARTI, as monitoring is being continued by these organisations.